In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The price of Avanos Medical Inc (NYSE: AVNS) closed at $11.91 in the last session, down -3.01% from day before closing price of $12.28. In other words, the price has decreased by -$3.01 from its previous closing price. On the day, 1.31 million shares were traded. AVNS stock price reached its highest trading level at $12.26 during the session, while it also had its lowest trading level at $11.85.
Ratios:
We take a closer look at AVNS’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.12 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 6.29. For the most recent quarter (mrq), Quick Ratio is recorded 1.58 and its Current Ratio is at 2.64. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.15.
On May 22, 2023, CL King started tracking the stock assigning a Buy rating and target price of $31.
Stephens Downgraded its Overweight to Equal-Weight on August 04, 2021, whereas the target price for the stock was revised from $60 to $45.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 13 ’25 when BLACKFORD GARY bought 40,000 shares for $10.99 per share. The transaction valued at 439,800 led to the insider holds 40,000 shares of the business.
BLACKFORD GARY bought 20,000 shares of AVNS for $219,500 on Aug 13 ’25. The Director now owns 91,593 shares after completing the transaction at $10.97 per share. On Mar 06 ’25, another insider, Holbrook Kerr, who serves as the SVP, Chief Commercial Officer of the company, sold 7,000 shares for $15.25 each. As a result, the insider received 106,778 and left with 82,047 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVNS now has a Market Capitalization of 552653504 and an Enterprise Value of 599653568. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.80 while its Price-to-Book (P/B) ratio in mrq is 0.71. Its current Enterprise Value per Revenue stands at 0.866 whereas that against EBITDA is 6.791.
Stock Price History:
The Beta on a monthly basis for AVNS is 1.16, which has changed by -0.4976803 over the last 52 weeks, in comparison to a change of 0.1653893 over the same period for the S&P500. Over the past 52 weeks, AVNS has reached a high of $25.36, while it has fallen to a 52-week low of $9.30. The 50-Day Moving Average of the stock is 2.51%, while the 200-Day Moving Average is calculated to be -13.38%.
Shares Statistics:
According to the various share statistics, AVNS traded on average about 597.73K shares per day over the past 3-months and 629240 shares per day over the past 10 days. A total of 46.31M shares are outstanding, with a floating share count of 44.75M. Insiders hold about 3.58% of the company’s shares, while institutions hold 96.91% stake in the company. Shares short for AVNS as of 1756425600 were 2734260 with a Short Ratio of 4.57, compared to 1753920000 on 1902726. Therefore, it implies a Short% of Shares Outstanding of 2734260 and a Short% of Float of 8.3500005.
